NEW YORK (GenomeWeb) — French diagnostics firm Novacyt said today that it plans to divest its Novaprep cytology business and clinical laboratory operations in order to focus on in vitro diagnostic product development and its profitable Lab21 and Primerdesign diagnostic reagent units.